Nationwide Case Review · 2026
Used Zantac and Later Diagnosed With Cancer?
Cornerstone Law Can Help.
Over 5,000 active cases in California's JCCP No. 5150, with additional active dockets in Delaware and Illinois. State courts are allowing claims to proceed where the federal MDL was dismissed, with bellwether trials expected in 2027. Cornerstone Law is reviewing cases nationwide — with no upfront cost to you.
Zantac (ranitidine) was recalled after testing revealed it could degrade into NDMA, a potent carcinogen. Plaintiffs allege manufacturers knew ranitidine was chemically unstable, that NDMA levels increased during storage and at elevated temperatures, and that these cancer risks were never disclosed to consumers. While the federal MDL was dismissed on expert-exclusion grounds, state courts have reached the opposite conclusion, and active litigation continues in thousands of cases nationwide.
5,000+
Active cases in California JCCP No. 5150
3+
Active state-court dockets (CA, DE, IL)
2027
Bellwether trials expected
NDMA
Carcinogen formed by ranitidine degradation
Federal vs. State Courts
Why State-Court Litigation Is Where the Action Is
The Zantac litigation has a unique procedural posture: the federal MDL was dismissed after the judge excluded plaintiffs' general-causation experts, but state courts, applying different evidentiary standards, have ruled the opposite way, allowing expert testimony and keeping thousands of cases alive.
Federal MDL No. 2924 — S.D. Florida
Federal MDL: Dismissed
- Judge excluded plaintiffs' general-causation experts under Daubert
- Without expert testimony, all claims were effectively dismissed
- Does not bind state courts operating under different evidentiary rules
JCCP No. 5150 — Alameda County, California
California: 5,000+ Cases Active
- Judge Evelio Grillo ruled plaintiffs' experts may testify
- Over 5,000 active cases under coordinated proceedings
- Discovery ongoing; bellwether trials expected in 2027
Delaware Superior Court
Delaware: Claims Proceeding
- Court denied defendants' motions to dismiss in 2025
- Bladder, stomach, liver, and esophageal cancer claims allowed to proceed
- Discovery orders compelling production of stability data and internal communications
The federal dismissal doesn't end your claim. State courts are applying independent standards and have consistently allowed plaintiffs' expert testimony. If you used Zantac and developed cancer, viable claims remain in California, Delaware, Illinois, and other state courts.
Latest Developments, 2025–2026
What's Happening in State-Court Zantac Litigation
- Discovery orders are compelling key evidence — courts have ordered production of stability testing data, NDMA-formation analyses, and internal communications regarding the recall
- Delaware motions to dismiss were denied (2025) — bladder, stomach, liver, and esophageal cancer claims are all proceeding in Delaware Superior Court
- California's JCCP is fully active — over 5,000 cases under coordinated proceedings before Judge Grillo in Alameda County, with bellwether selection underway
- Illinois state-court cases are active — additional coordinated proceedings in Illinois courts are expanding the overall docket
- Bellwether trials are expected in 2027 — early state-court verdicts will establish case values and drive settlement negotiations across all active dockets
Eligibility
Are You a Victim? Who May Qualify?
You may qualify if you used Zantac (ranitidine), whether prescription or over-the-counter, and were later diagnosed with a qualifying cancer. Both short-term and long-term users may be eligible depending on their diagnosis and exposure history.
Qualifying Cancer Diagnoses
- Bladder cancer
- Stomach cancer
- Liver cancer
- Pancreatic cancer
- Esophageal cancer
- Colorectal cancer
General Eligibility Factors
- Used Zantac (ranitidine), prescription or OTC
- Developed a qualifying cancer diagnosis
- Diagnosis documented by a physician
- Able to identify approximate duration and frequency of use
Legal Theories and Damages
Liability and What You Can Recover
Liability Legal Theories
- Failure to warn
- Defective design
- Negligent misrepresentation
- Breach of implied warranty
- Negligent failure to recall
- Consumer protection statute violations
Damages What You Can Recover
- Medical expenses (past and future)
- Lost income and reduced earning capacity
- Pain and suffering
- Emotional distress
- Wrongful death damages
- Punitive damages for reckless conduct
Common Questions
What Clients Ask Us Most
I heard the federal case was dismissed — does that mean I can't file?
No. The federal dismissal doesn't bind state courts, which are applying independent standards and have consistently allowed the same expert testimony the federal court excluded. Viable claims remain active in California, Delaware, and Illinois.
What does it cost to work with Cornerstone Law?
We handle Zantac cases on contingency — no upfront fee, and we only get paid if we recover compensation for you.
I don't live in California, Delaware, or Illinois — can I still file?
Often, yes. Where your case can be filed depends on several factors beyond your home state. Reach out and we can help determine the best venue for your claim.
How long do I have to file?
Deadlines vary by state and by the date of diagnosis, so it's worth having your specific timeline reviewed rather than assuming you've missed a window.
Why Cornerstone Law: We track every development in California's JCCP, Delaware Superior Court, and Illinois state courts, so our clients are positioned for the strongest possible recovery ahead of 2027 bellwether trials.
Cornerstone Law Is Reviewing Zantac Cancer Cases Nationwide
We represent individuals in active state-court Zantac litigation. Find out whether your diagnosis and use history qualify for a claim.
Get a Free Case Review
No fee unless we recover compensation for you. Call 1-800-928-9445.
This page is for informational purposes only and does not constitute legal advice. Prior results do not guarantee a similar outcome in any future case. This is a paid legal advertisement from Cornerstone Law, LLP. Attorney Frank Zeccola, Esq., licensed to practice law in California, is responsible for this advertisement.
